CHEST Foundation and the Alpha-1 Foundation Research Grant in Alpha-1 Antitrypsin Deficiency

Funding Agency:
Alpha-1 Foundation

2017 marks the 11th year of the successful partnership between the CHEST Foundation and Alpha–1 Foundation in sponsoring a 1-year clinical research grant in alpha–1 antitrypsin (AAT) deficiency. The Alpha–1 Foundation is committed to finding a cure for alpha–1 antitrypsin (AAT) deficiency and to improving the lives of people affected by alpha–1 worldwide. Its grants and awards programs fund a broad range of research that leads to improvements in the health and quality of life of people living with AAT.

Deadline: Mar. 31, 2017

Agency Website

Eligibility Requirements

• CHEST membership at time of application. • Although applicants may be at later career stages, special consideration will be given to those within 5 years of completing an advanced training program. o Or equivalent experience. • The performance site must have a federal-wide assurance with the NIH for the protection of human subjects; not-for-profit organizations and institutions are eligible to apply.



Funding Type



Junior Faculty


Medical - Clinical Science
Medical - Translational

External Deadline

March 31, 2017